A major international trial suggests an experimental anti-clotting drug may lower the risk of repeat strokes without the dangerous bleeding complications tied to many current treatments. For decades, stroke specialists have faced a frustrating tradeoff: stronger anti-clotting drugs can reduce the risk of another stroke, but they also raise the danger of serious bleeding. Now, [...]